You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • FRI0211 Tapering MTX versus Steady-State MTX in Combination with Tocilizumab for Treatment of Rheumatoid Arthritis (ACT-TAPER): A Randomised, Double-Blind, Controlled Phase 4 Trial

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
FRI0211 Tapering MTX versus Steady-State MTX in Combination with Tocilizumab for Treatment of Rheumatoid Arthritis (ACT-TAPER): A Randomised, Double-Blind, Controlled Phase 4 Trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Edwards C, Kiely P, Ostor A, et al
FRI0211 Tapering MTX versus Steady-State MTX in Combination with Tocilizumab for Treatment of Rheumatoid Arthritis (ACT-TAPER): A Randomised, Double-Blind, Controlled Phase 4 Trial
Annals of the Rheumatic Diseases 2016;75:508.